icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back grey_arrow_rt.gif
 
 
 
COMPARATIVE EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR VERSUS SOFOSBUVIR/VELPATASVIR IN PATIENTS WITH HEPATITIS C: A MULTICENTER PROSPECTIVE STUDY
 
 
  AASLD 2026 Denver
 
A. KIM 1 1 Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.

1107261copy

1107262copy

1107263copy

1107264copy

1107265copy

1107266copy

1107267copy